Find Elinzanetant manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

0

CEP/COS

0

JDMF

0

EU WC

0

KDMF

0

NDC API

0

VMF

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Europe

0

Canada

0

Australia

0

South Africa

0

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

API/FDF Prices: Book a Demo

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Unii-nzw2bow35n, 929046-33-3, Nt-814, Elinzanetant [inn], Elinzanetant [usan], Nzw2bow35n
Molecular Formula
C33H35F7N4O3
Molecular Weight
668.6  g/mol
InChI Key
DWRIJNIPBUFCQS-DQEYMECFSA-N
FDA UNII
NZW2BOW35N

Elinzanetant
1 2D Structure

Elinzanetant

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[6-[(7S,9aS)-7-(hydroxymethyl)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-4-(4-fluoro-2-methylphenyl)pyridin-3-yl]-2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethylpropanamide
2.1.2 InChI
InChI=1S/C33H35F7N4O3/c1-19-9-23(34)5-6-26(19)27-13-29(44-16-25-18-47-8-7-43(25)15-24(44)17-45)41-14-28(27)42(4)30(46)31(2,3)20-10-21(32(35,36)37)12-22(11-20)33(38,39)40/h5-6,9-14,24-25,45H,7-8,15-18H2,1-4H3/t24-,25-/m0/s1
2.1.3 InChI Key
DWRIJNIPBUFCQS-DQEYMECFSA-N
2.1.4 Canonical SMILES
CC1=C(C=CC(=C1)F)C2=CC(=NC=C2N(C)C(=O)C(C)(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CC5COCCN5CC4CO
2.1.5 Isomeric SMILES
CC1=C(C=CC(=C1)F)C2=CC(=NC=C2N(C)C(=O)C(C)(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4C[C@H]5COCCN5C[C@H]4CO
2.2 Other Identifiers
2.2.1 UNII
NZW2BOW35N
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Unii-nzw2bow35n

2. 929046-33-3

3. Nt-814

4. Elinzanetant [inn]

5. Elinzanetant [usan]

6. Nzw2bow35n

7. Bay3427080

8. Bay-3427080

9. 2-(3,5-bis(trifluoromethyl)phenyl)-n-(4-(4-fluoro-2-methylphenyl)-6-((7s,9as)-7-(hydroxymethyl)hexahydropyrazino(2,1-c)(1,4)oxazin-8(1h)-yl)-3-pyridinyl)-n,2-dimethylpropanamide

10. 2-[3,5-bis(trifluoromethyl)phenyl]-n-{4-(4-fluoro-2-methylphenyl)-6-[(7s,9as)-7-(hydroxymethyl)hexahydropyrazino[2,1-c][1,4]oxazin-8(1h)-yl]-3-pyridinyl}-n,2-dimethylpropanamide

11. Elinzanetant [who-dd]

12. Schembl303180

13. Chembl4802157

14. Dtxsid101337049

15. Ex-a6225

16. Who 10952

17. Hy-109171

18. Cs-0116361

19. 2-[3,5-bis(trifluoromethyl)phenyl]-n-{4-(4-fluoro-2-methylphenyl)-6-[(7s,9as)-7-(hydroxymethyl)hexahydropyrazino[2,1-c][1,4]oxazin-8(1h)-yl]pyridin-3-yl}-n,2-dimethylpropanamide

20. Benzamide, 3-(5-methyl-2-tbenzeneacetamide, N-(4-(4-fluoro-2-methylphenyl)-6-((7s,9as)-hexahydro-7-(hydroxymethyl)pyrazino(2,1-c)(1,4)oxazin-8(1h)-yl)-3-pyridinyl)-n,.alpha.,.alpha.-trimethyl-3,5-bis(trifluoromethyl)-

21. Benzamide, 3-(5-methyl-2-tbenzeneacetamide, N-(4-(4-fluoro-2-methylphenyl)-6-((7s,9as)-hexahydro-7-(hydroxymethyl)pyrazino(2,1-c)(1,4)oxazin-8(1h)-yl)-3-pyridinyl)-n,alpha,alpha-trimethyl-3,5-bis(trifluoromethyl)-

22. N-[6-[(7s,9as)-7-(hydroxymethyl)-3,4,6,7,9,9a-hexahydro-1h-pyrazino[2,1-c][1,4]oxazin-8-yl]-4-(4-fluoro-2-methylphenyl)pyridin-3-yl]-2-[3,5-bis(trifluoromethyl)phenyl]-n,2-dimethylpropanamide

2.4 Create Date
2007-05-22
3 Chemical and Physical Properties
Molecular Weight 668.6 g/mol
Molecular Formula C33H35F7N4O3
XLogP35.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count13
Rotatable Bond Count6
Exact Mass668.25973813 g/mol
Monoisotopic Mass668.25973813 g/mol
Topological Polar Surface Area69.1 Ų
Heavy Atom Count47
Formal Charge0
Complexity1060
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Bayer AG

Germany
International Sweetener Colloquium
Not Confirmed
arrow

Bayer AG

Germany
arrow
International Sweetener Colloquium
Not Confirmed

ELINZANETANT

Brand Name : LYNKUET

Dosage Form : CAPSULE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2025-10-24

Application Number : 219469

Regulatory Info : RX

Registration Country : USA

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

BAYER HLTHCARE

Germany
International Sweetener Colloquium
Not Confirmed
arrow

BAYER HLTHCARE

Germany
arrow
International Sweetener Colloquium
Not Confirmed

ELINZANETANT

Brand Name : LYNKUET

Dosage Form : CAPSULE;ORAL

Dosage Strength : 60MG

Approval Date : 2025-10-24

Application Number : 219469

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

STOCK RECAP #PipelineProspector

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

arrow
International Sweetener Colloquium
Not Confirmed

BAYER HLTHCARE

Germany
arrow
International Sweetener Colloquium
Not Confirmed

ELINZANETANT

US Patent Number : 10195205

Drug Substance Claim :

Drug Product Claim :

Application Number : 219469

Patent Use Code : U-3622

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-05-18

blank

02

arrow
International Sweetener Colloquium
Not Confirmed

BAYER HLTHCARE

Germany
arrow
International Sweetener Colloquium
Not Confirmed

ELINZANETANT

US Patent Number : 7683056

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 219469

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-09-15

blank

03

arrow
International Sweetener Colloquium
Not Confirmed

BAYER HLTHCARE

Germany
arrow
International Sweetener Colloquium
Not Confirmed

ELINZANETANT

US Patent Number : 10774091

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 219469

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-03-13

blank

04

arrow
International Sweetener Colloquium
Not Confirmed

BAYER HLTHCARE

Germany
arrow
International Sweetener Colloquium
Not Confirmed

ELINZANETANT

US Patent Number : 12264164

Drug Substance Claim :

Drug Product Claim :

Application Number : 219469

Patent Use Code : U-3622

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-03-13

blank

05

arrow
International Sweetener Colloquium
Not Confirmed

BAYER HLTHCARE

Germany
arrow
International Sweetener Colloquium
Not Confirmed

ELINZANETANT

US Patent Number : 11787820

Drug Substance Claim :

Drug Product Claim :

Application Number : 219469

Patent Use Code : U-3622

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-03-13

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Looking for 929046-33-3 / Elinzanetant API manufacturers, exporters & distributors?

Elinzanetant manufacturers, exporters & distributors 1

23

PharmaCompass offers a list of Elinzanetant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Elinzanetant manufacturer or Elinzanetant supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Elinzanetant manufacturer or Elinzanetant supplier.

PharmaCompass also assists you with knowing the Elinzanetant API Price utilized in the formulation of products. Elinzanetant API Price is not always fixed or binding as the Elinzanetant Price is obtained through a variety of data sources. The Elinzanetant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Elinzanetant

Synonyms

Unii-nzw2bow35n, 929046-33-3, Nt-814, Elinzanetant [inn], Elinzanetant [usan], Nzw2bow35n

Cas Number

929046-33-3

Unique Ingredient Identifier (UNII)

NZW2BOW35N

Elinzanetant Manufacturers

A Elinzanetant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Elinzanetant, including repackagers and relabelers. The FDA regulates Elinzanetant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Elinzanetant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Elinzanetant manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Elinzanetant Suppliers

A Elinzanetant supplier is an individual or a company that provides Elinzanetant active pharmaceutical ingredient (API) or Elinzanetant finished formulations upon request. The Elinzanetant suppliers may include Elinzanetant API manufacturers, exporters, distributors and traders.

click here to find a list of Elinzanetant suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Elinzanetant GMP

Elinzanetant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Elinzanetant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Elinzanetant GMP manufacturer or Elinzanetant GMP API supplier for your needs.

Elinzanetant CoA

A Elinzanetant CoA (Certificate of Analysis) is a formal document that attests to Elinzanetant's compliance with Elinzanetant specifications and serves as a tool for batch-level quality control.

Elinzanetant CoA mostly includes findings from lab analyses of a specific batch. For each Elinzanetant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Elinzanetant may be tested according to a variety of international standards, such as European Pharmacopoeia (Elinzanetant EP), Elinzanetant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Elinzanetant USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty